Olympus Corporation

TSE:7733 Stock Report

Market Cap: JP¥2.0t

Olympus Future Growth

Future criteria checks 2/6

Olympus is forecast to grow earnings and revenue by 7.1% and 4.4% per annum respectively. EPS is expected to grow by 7.5% per annum. Return on equity is forecast to be 13.3% in 3 years.

Key information

7.1%

Earnings growth rate

7.54%

EPS growth rate

Medical Equipment earnings growth10.2%
Revenue growth rate4.4%
Future return on equity13.31%
Analyst coverage

Good

Last updated28 Aug 2025

Recent future growth updates

Earnings Miss: Olympus Corporation Missed EPS By 50% And Analysts Are Revising Their Forecasts

Aug 12
Earnings Miss: Olympus Corporation Missed EPS By 50% And Analysts Are Revising Their Forecasts

Olympus Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

May 16
Olympus Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Recent updates

Earnings Miss: Olympus Corporation Missed EPS By 50% And Analysts Are Revising Their Forecasts

Aug 12
Earnings Miss: Olympus Corporation Missed EPS By 50% And Analysts Are Revising Their Forecasts

A Look At The Intrinsic Value Of Olympus Corporation (TSE:7733)

Jul 25
A Look At The Intrinsic Value Of Olympus Corporation (TSE:7733)

Subdued Growth No Barrier To Olympus Corporation's (TSE:7733) Price

Jul 09
Subdued Growth No Barrier To Olympus Corporation's (TSE:7733) Price

Olympus (TSE:7733) Seems To Use Debt Quite Sensibly

Jun 17
Olympus (TSE:7733) Seems To Use Debt Quite Sensibly

Olympus Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

May 16
Olympus Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Does This Valuation Of Olympus Corporation (TSE:7733) Imply Investors Are Overpaying?

Apr 22
Does This Valuation Of Olympus Corporation (TSE:7733) Imply Investors Are Overpaying?

The Returns At Olympus (TSE:7733) Aren't Growing

Apr 07
The Returns At Olympus (TSE:7733) Aren't Growing

Investors Appear Satisfied With Olympus Corporation's (TSE:7733) Prospects

Mar 22
Investors Appear Satisfied With Olympus Corporation's (TSE:7733) Prospects

These 4 Measures Indicate That Olympus (TSE:7733) Is Using Debt Reasonably Well

Feb 01
These 4 Measures Indicate That Olympus (TSE:7733) Is Using Debt Reasonably Well

A Look At The Intrinsic Value Of Olympus Corporation (TSE:7733)

Jan 17
A Look At The Intrinsic Value Of Olympus Corporation (TSE:7733)
User avatar

Cloud-Powered Endoscopy Innovation Fuels Revenue Growth In The Medical Devices Industry

Approval of AI endoscopy devices in the U.S. and Europe is expected to drive revenue growth through improved clinical outcomes and procedural efficiency.

Olympus' (TSE:7733) Strong Earnings Are Of Good Quality

Nov 15
Olympus' (TSE:7733) Strong Earnings Are Of Good Quality

Olympus Corporation's (TSE:7733) Share Price Could Signal Some Risk

Nov 07
Olympus Corporation's (TSE:7733) Share Price Could Signal Some Risk

Olympus (TSE:7733) Hasn't Managed To Accelerate Its Returns

Oct 12
Olympus (TSE:7733) Hasn't Managed To Accelerate Its Returns

A Look At The Intrinsic Value Of Olympus Corporation (TSE:7733)

Sep 27
A Look At The Intrinsic Value Of Olympus Corporation (TSE:7733)

Earnings and Revenue Growth Forecasts

TSE:7733 - Analysts future estimates and past financials data (JPY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
3/31/20281,070,944122,58495,604182,18013
3/31/20271,029,936117,94689,947173,93615
3/31/2026973,83189,18082,319164,94911
6/30/2025969,023112,00581,794152,003N/A
3/31/2025997,332117,800125,254190,463N/A
12/31/2024993,33496,432118,411181,525N/A
9/30/2024973,59587,72681,759147,854N/A
6/30/2024966,04627,88456,269118,734N/A
3/31/2024936,21026,610-22,25942,365N/A
12/31/2023916,09239,468-36,58330,686N/A
9/30/2023901,50756,53411,19580,406N/A
6/30/2023875,586126,381-1,68072,238N/A
3/31/2023881,923137,80927,86798,490N/A
12/31/2022933,645137,62345,131109,416N/A
9/30/2022925,858126,84847,185107,203N/A
6/30/2022891,410121,91260,183119,188N/A
3/31/2022868,867115,742107,958169,729N/A
12/31/2021793,72795,27485,693150,356N/A
9/30/2021774,11398,06390,544155,506N/A
6/30/2021785,41184,46778,484139,415N/A
3/31/2021730,54465,59964,895124,122N/A
12/31/2020715,92446,44355,563116,827N/A
9/30/2020724,72241,45942,698103,723N/A
6/30/2020752,17642,85550,303113,526N/A
3/31/2020797,41151,67067,615133,544N/A
12/31/2019807,88760,75872,843136,095N/A
9/30/2019801,20249,70444,493106,769N/A
6/30/2019795,19333,4698,58670,321N/A
3/31/2019793,8628,147N/A66,943N/A
12/31/2018795,47915,554N/A71,514N/A
9/30/2018798,91521,732N/A79,978N/A
6/30/2018795,20530,324N/A100,036N/A
3/31/2018786,49757,064N/A95,146N/A
12/31/2017786,60885,083N/AN/AN/A
9/30/2017767,50885,830N/A91,430N/A
6/30/2017751,45879,716N/AN/AN/A
3/31/2017748,05078,191N/A90,194N/A
12/31/2016745,54360,888N/AN/AN/A
9/30/2016758,77748,983N/A35,146N/A
6/30/2016785,44454,390N/AN/AN/A
3/31/2016804,57862,594N/A48,621N/A
12/31/2015807,1972,188N/AN/AN/A
9/30/2015805,4324,742N/A92,093N/A
6/30/2015785,230-144N/AN/AN/A
3/31/2015764,671-8,737N/A66,811N/A
12/31/2014749,62739,710N/AN/AN/A
9/30/2014734,46943,896N/A72,544N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 7733's forecast earnings growth (7.1% per year) is above the savings rate (0.5%).

Earnings vs Market: 7733's earnings (7.1% per year) are forecast to grow slower than the JP market (8.2% per year).

High Growth Earnings: 7733's earnings are forecast to grow, but not significantly.

Revenue vs Market: 7733's revenue (4.4% per year) is forecast to grow faster than the JP market (4.3% per year).

High Growth Revenue: 7733's revenue (4.4% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 7733's Return on Equity is forecast to be low in 3 years time (13.3%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/09/03 16:56
End of Day Share Price 2025/09/03 00:00
Earnings2025/06/30
Annual Earnings2025/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Olympus Corporation is covered by 30 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Warren LauAletheia Analyst Network Limited
Masahiro NakanomyoBarclays
Kunihiko KannoBNP Paribas Securities (Asia)